7 hasil untuk "Giulia Musso"

Diagnostic performance of an immunoblot assay for anti-F-actin antibodies in type 1 autoimmune hepatitis

Giulia Musso; Nicoletta Gallo; Daniela Basso

LabMed Discovery, Vol. 2 No. 3 · 2025 · Inggris · DOAJ Scopus

Autoimmune hepatitis (AIH) is a liver disease of unknown cause characterized by hypergammaglobulinemia, typical or compatible liver histology, the absence of viral hepatitis and the production of autoantibodies. Anti-smooth muscle antibodies (SMAs) detected with indirect immunofluorescence (IIF) in…

Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases

Andrea Padoan; Giulia Musso; Nicole Contran dkk.

Current Issues in Molecular Biology, Vol. 45 No. 7 · 2023 · Inggris · DOAJ Scopus

In this review, the role of innate and adaptive immunity in the pathogenesis of inflammatory bowel diseases (IBD) is reported. In IBD, an altered innate immunity is often found, with increased Th17 and decreased Treg cells infiltrating the intestinal mucosa. An associated increase in inflammatory…

Salivary alpha-amylase: A marker of stress in gynecological residents during a shoulder dystocia simulation scenario

Ada Aita; Paola Galozzi; Filippo Zemin dkk.

PLOS ONE, Vol. 19 No. 11 · 2024 · Inggris · PLOS Scopus

Objective: Salivary alpha-amylase (sAA) has been recently proposed as biomarker of stress responsiveness within the sympathetic nervous system, preferable to cortisol, since limitations related to cortisol measurement (e.g. diurnal and seasonal rhythms, drugs interferences). Several factors, as…

Juga tersedia di: DOAJ

Distinct neurostructural, cognitive, and neuropsychiatric associations of plasma p-tau217, and Aβ42/40 in Parkinson’s disease and aging cohorts

Eleonora Fiorenzato; Simone Cauzzo; Giulia Musso dkk.

Frontiers in Aging Neuroscience, Vol. 18 · 2026 · Inggris · DOAJ Scopus

ObjectiveAlzheimer’s disease (AD) co-pathology may contribute to cognitive decline and faster progression in Parkinson’s disease (PD). Although blood-based biomarkers enable biological staging along the AD continuum, their contribution in the clinical-biological characterization of PD phenotypes…

Detecting amyloid and tau pathology in Parkinson’s disease, 4R-tauopathies and control subjects with plasma pTau217

Giulia Musso; Eleonora Fiorenzato; Valentina Misenti dkk.

Frontiers in Neurology, Vol. 16 · 2025 · Inggris · DOAJ Scopus

IntroductionPlasma phospho-tau 217 (pTau217) is a biomarker for Alzheimer’s disease (AD) pathology, reflecting amyloid (Aβ) and tau burden, but its role in Parkinson disease (PD) and 4-repeat(4R)-tauopathies remains incompletely understood. We measured plasma pTau217 across the cognitive spectrum…

Evaluation of peripherin in biofluids of patients with motor neuron diseases

Daniele Sabbatini; Flavia Raggi; Susanna Ruggero dkk.

Annals of Clinical and Translational Neurology, Vol. 8 No. 8 · 2021 · Inggris · DOAJ Scopus

Abstract Peripherin (PRPH), a type III intermediate filament, assembles with neurofilaments in neurons of the peripheral nervous system, including lower motor neurons (LMN). To evaluate the role of PRPH in LMN degeneration, we assessed PRPH and neurofilament light chain (NfL) in cerebrospinal fluid…